102 related articles for article (PubMed ID: 1607676)
21. Antiprotease activity in urine of patients with inflammatory skin disorders.
Streit V; Wiedow O; Bartels J; Christophers E
J Invest Dermatol; 1995 Oct; 105(4):562-6. PubMed ID: 7561159
[TBL] [Abstract][Full Text] [Related]
22. SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis.
Kuijpers AL; Pfundt R; Zeeuwen PL; Molhuizen HO; Mariman EC; van de Kerkhof PC; Schalkwijk J
Clin Genet; 1998 Jul; 54(1):96-101. PubMed ID: 9727750
[TBL] [Abstract][Full Text] [Related]
23. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.
Molhuizen HO; Zeeuwen PL; Olde Weghuis D; Geurts van Kessel A; Schalkwijk J
Cytogenet Cell Genet; 1994; 66(2):129-31. PubMed ID: 8287685
[TBL] [Abstract][Full Text] [Related]
24. Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI.
Molhuizen HO; Schalkwijk J
Biol Chem Hoppe Seyler; 1995 Jan; 376(1):1-7. PubMed ID: 7612183
[TBL] [Abstract][Full Text] [Related]
25. Development of a keratinocyte-based screening model for antipsoriatic drugs using green fluorescent protein under the control of an endogenous promoter.
Pol A; van Ruissen F; Schalkwijk J
J Biomol Screen; 2002 Aug; 7(4):325-32. PubMed ID: 12230886
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
[TBL] [Abstract][Full Text] [Related]
27. Development and application of monoclonal antibodies against SKALP/elafin and other trappin family members.
Vandermeeren M; Daneels G; Bergers M; van Vlijmen-Willems I; Pol A; Geysen J; Schalkwijk J
Arch Dermatol Res; 2001 Jul; 293(7):343-9. PubMed ID: 11550807
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of detergents on keratinocyte gene expression.
van Ruissen F; Le M; Carroll JM; van der Valk PG; Schalkwijk J
J Invest Dermatol; 1998 Apr; 110(4):358-63. PubMed ID: 9540975
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus.
Yamamoto S; Egami H; Kurizaki T; Ohmachi H; Hayashi N; Okino T; Shibata Y; Schalkwijk J; Ogawa M
Br J Cancer; 1997; 76(8):1081-6. PubMed ID: 9376270
[TBL] [Abstract][Full Text] [Related]
30. Antileukoprotease in psoriatic scales.
Wiedow O; Young JA; Davison MD; Christophers E
J Invest Dermatol; 1993 Sep; 101(3):305-9. PubMed ID: 8370966
[TBL] [Abstract][Full Text] [Related]
31. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J
Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
[TBL] [Abstract][Full Text] [Related]
33. A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes.
Pol A; Bergers M; van Ruissen F; Pfundt R; Schalkwijk J
Skin Pharmacol Appl Skin Physiol; 2002; 15(4):252-61. PubMed ID: 12218287
[TBL] [Abstract][Full Text] [Related]
34. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry.
Suzuki Y; Furukawa M; Abe J; Kashiwagi M; Hirose S
Histochem Cell Biol; 2000 Jul; 114(1):15-20. PubMed ID: 10959818
[TBL] [Abstract][Full Text] [Related]
35. The inflammatory and proliferative response of normal skin in a model for acute chemical injury: ornithine decarboxylase induction as a common feature in various models for acute skin injury.
Van Duijnhoven-Avontuur WM; Alkemade JA; Schalkwijk J; Mier PD; Van der Valk PG
Br J Dermatol; 1994 Jun; 130(6):725-30. PubMed ID: 8011497
[TBL] [Abstract][Full Text] [Related]
36. The impact of salt water soaks on biophysical and molecular parameters in psoriatic epidermis equivalents.
Gambichler T; Demetriou C; Terras S; Bechara FG; Skrygan M
Dermatology; 2011; 223(3):230-8. PubMed ID: 22056695
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
[TBL] [Abstract][Full Text] [Related]
38. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes.
Wingens M; van Bergen BH; Hiemstra PS; Meis JF; van Vlijmen-Willems IM; Zeeuwen PL; Mulder J; Kramps HA; van Ruissen F; Schalkwijk J
J Invest Dermatol; 1998 Dec; 111(6):996-1002. PubMed ID: 9856807
[TBL] [Abstract][Full Text] [Related]
39. Purification of a serine-proteinase inhibitor from human articular cartilage. Identity with the acid-stable proteinase inhibitor of mucous secretions.
Böhm B; Deutzmann R; Burkhardt H
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):269-73. PubMed ID: 2001242
[TBL] [Abstract][Full Text] [Related]
40. Inter-alpha-inhibitor in urine and calcium oxalate urinary crystals.
Dawson CJ; Grover PK; Ryall RL
Br J Urol; 1998 Jan; 81(1):20-6. PubMed ID: 9467471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
